Effect of cytomegalovirus immediate early gene products on endothelial cell gene activity

Cardiovascular Research

Volumn 50, Issue 3, 2001, Pages 538-546

  Guetta, Esther ^a   Scarpati, Eleonora M ^b   Dicorleto, Paul E ^c  

^a TEL AVIV UNIVERSITY   (Israel)

^b Biex   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Atherosclerosis; Cell culture isolation; Endothelial factors; Gene expression; Infection inflammation

Indexed keywords

CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GENE PRODUCT; GROWTH FACTOR; PROCOAGULANT; THROMBIN; TRANSCRIPTION FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CATTLE; CELL GROWTH; CONTROLLED STUDY; CYTOMEGALIC INCLUSION BODY DISEASE; DNA VECTOR; ENDOTHELIUM CELL; FETUS; GENE ACTIVITY; GENE EXPRESSION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MONOCYTE; NONHUMAN; PLASMID; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE;

ANIMALS; CATTLE; CELL ADHESION; CELL CULTURE TECHNIQUES; CYTOMEGALOVIRUS; E-SELECTIN; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; GENE EXPRESSION REGULATION, VIRAL; GENES, IMMEDIATE-EARLY; HUMANS; IMMEDIATE-EARLY PROTEINS; MONOCYTES; PLATELET-DERIVED GROWTH FACTOR; PROMOTER REGIONS (GENETICS); THROMBIN; TRANSFECTION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0034999370     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(01)00269-3     Document Type: Article

References (56)

1. Melnick J.L., Adam E., Debakey M.E. Cytomegalovirus and atherosclerosis. BioEssays. 17:1995;899-903.
2. Melnick J.L., Hu C., Burek J., et al. Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. J. Med. Virol. 42:1994;170-174.
3. Horvath R., Cerny J., Benedik J. Jr, et al. The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis. J. Clin. Virol. 16:2000;17-24.
4. Hendrix M.G.R., Dormans P.H., Kitslaar P., et al. The presence of cytomegalovirus nucleic acids in arterial walls of atherosclerotic and nonatherosclerotic patients. Am J Pathol. 134:1989;23-28.
5. Grattan M.T. Accelerated graft atherosclerosis following cardiac transplantation: clinical perspectives. Clin. Cardiol. 14:(suppl II):1991;16-20.
6. Zhou Y.F., Shou M., Guetta E., et al. Cytomegalovirus infection of rats increases the neointimal response to vascular injury, and does so without consistent evidence of direct infection of the vascular wall. Circulation. 100:1999;1569-1575.
7. Lemstrom K.B., Bruning J.H., Bruggeman C.A., et al. Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts. J. Clin. Invest. 92:1993;549-558.
8. Hajjar D.P., Fabricant C.G., Minick C.R., et al. Virus-induced atherosclerosis: herpes virus infection alters aortic cholesterol metabolism and accumulation. Am. J. Pathol. 122:1986;62-70.
9. Hajjar D.P., Pomerantz K.B., Falcone D.J., et al. Herpes simplex virus infection in human arterial cells. Implications in arteriosclerosis. J. Clin. Invest. 80:1987;1317-1321.
10. Zhou Y.F., Yu Z.X., Wanishsawad C., et al. The immediate early gene products of human cytomegalovirus increase vascular smooth muscle cell migration, proliferation, and expression of PDGF β-receptor. Biochem. Biophs. Res. Commun. 256:1999;608-613.
11. Zhou Y.F., Guetta E., Yu Z.X., et al. Human cytomegalovirus Increases modified low density lipoprotein uptake and scavenger receptor mRNA expression in vascular smooth muscle cells. J. Clin. Invest. 98:1996;2129-2138.
12. Speir E., Shibutali T., Yu Z.X., et al. Role of reactive oxygen intermediates in cytomegalovirus gene expression and in the response of human smooth muscle cells to viral infection. Cir. Res. 79:1996;1143-1152.
13. Span A.H., Van Dam-Mieras M.C.E., Mullers W., et al. The effect of virus infection on the adherence of leukocytes or platelets to endothelial cells. Eur. J. Clin. Invest. 21:1989;331-338.
14. Vercellotti G.M. Effects of viral activation of the vessel wall on inflammation. Blood Coagul. Fibrinolysi. S2:1998;S3-S6.
15. Van Dam-Mieras M.C.E., Muller A.D., van Hinsbergh V.W.M., et al. The procoagulant response of cytomegalovirus infected endothelial cells. Thromb. Haemost. 68:1992;364-370.
16. Bruggeman C.A. Cytomegalovirus and latency: an overview. Virchows Archiv. B Cell Pathol. 64:1993;325-333.
17. Epstein S.E., Speir E., Zhou Y.F., et al. The role of infection in restenosis and atherosclerosis: focus on cytomegalovirus. Lancet. 348:1996;s13-s17.49.
18. Mocarski E.S. Cytomegalovirus biology and replication. Roizman B., Whitley R., Lopez C. The human herpes viruses. 1993;173-226 Raven Press, New York.
19. Stinski M.F. Cytomegalovirus and its replication. Fields B.N. Virology. 1990;1959-1980 Raven Press, New York.
20. Ghazal P.J., Nelson J.A. Transcription factors and viral regulatory proteins as potential mediators of cytomegalovirus pathogenesis. Becker Y., Darai G. Molecular aspects of human cytomegalovirus diseases. 1993;360-383 Springer-Verlag, Berlin.
21. Myerson D., Hackman R.C., Nelson J.A., et al. Widespread presence of occult cytomegalovirus. Human Pathol. 15:1984;430-439.
22. Waldman W.J., Sneddon J.F., Stephens R.E., et al. Enhanced endothelial cytopathogenicity induced by a cytomegalovirus strain propagated in endothelial cells. J. Med. Virol. 28:1989;223-230.
23. Guetta E., Guetta V., Shibutani T., et al. Monocytes harboring cytomegalovirus: interactions with endothelial cells, smooth muscle cells and oxidized low density lipoprotein - possible mechanisms for activating virus delivered by monocytes to sites of vascular injury. Circ. Res. 81:1992;8-16.
24. DiCorleto P.E., De Lamotte C.A. Thrombin causes increased monocytic-cell adhesion to endothelial cells through a protein-kinase C-dependent pathway. Biochem. J. 264:1989;71-77.
25. Ades E.W., Candal F.J., Swerlick R.A., et al. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J. Invest. Dermatol. 99:1992;683-690.
26. Davis M.G., Huang E.S. Transfer and expression of plasmids containing human cytomegalovirus immediate-early gene 1 promoter-enhancer sequences in eukaryotic and prokaryotic cells. Biotechnol. Appl. Biochem. 10:1988;6-12.
27. Yurochko A.D., Kowalik T.F., Huong S.H., et al. Human cytomegalovirus upregulates NF-κB p105/p50 and p65 promoters. J. Virol. 69:1995;5391-5400.
28. Ghazal P.J., Young E., Giulietti E., et al. A discrete cis element in the human immunodeficiency virus long terminal repeat mediates synergistic trans activation by cytomegalovirus immediate-early proteins. J. Virol. 65:1991;6735-6742.
29. Scarpati E.M., DiCorleto P.E. Identification of a thrombin response element in the human platelet-derived growth factor B-chain (c-sis) promoter. J. Biol. Chem. 271:1996;3025-3032.
30. Iadermarco M.F., McQuillan J.J., Rosen G.D., et al. Characterization of the promoter for vascular adhesion molecule-1 (VCAM-1). J. Biol. Chem. 267:1992;16323-16329.
31. DiCorleto P.E., De la Motte C.A. Characterization of the adhesion of the human monocytic cell line U937 to cultured endothelial cells. J. Clin. Invest. 75:1985;1153-1161.
32. Kim S., Yu S.S., Lee I.S., et al. Human cytomegalovirus IE1 protein activates AP-1 through a cellular protein kinase(s). J. Gen. Virol. 80:1999;961-969.
33. Collins T., Read M.A., Neish A.S., et al. Transcritional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers. FASEB J. 9:1995;899-909.
34. Montgomery K.F., Osborn L., Hession C., et al. Activation of endothelial-leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Proc. Natl. Acad. Sci. USA. 88:1991;6523-6527.
35. Faruqi R., de la Motte C., DiCorleto P.E. Alpha-tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells. J. Clin. Invest. 94:1994;592-600.
36. Speir E., Yu Z.X., Ferrans V.J., Huang E.S., Epstein S.E. Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells. Circ Res. 83:1998;210-216.
37. Shahgasempour S., Woodroffe S.B., Garnett H.M. Alterations in the expression of ELAM-1, ICAM-1 and VCAM-1 after in vitro infection of endothelial cells with a clinical isolate of human cytomegalovirus. Microbiol. Immunol. 41:1997;121-129.
38. Sedmak D.D., Knight D.A., Vook N.C., et al. Divergent patterns of ELAM-1, ICAM-1, and VCAM-1 expression on cytomegalovirus-infected endothelial cells. Transplantation. 58:1994;1379-1385.
39. Ferns G.A.A., Rutherford C. Atherosclerosis and platelet derived growth factors. Cummins P. Growth factors and the cardiovascular system. 1993;169-187 Kluwer Academic, Norwell, MA.
40. Barrett T.B., Benditt E.P. Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall. Proc. Natl. Acad. Sci. USA. 85:1988;2810-2814.
41. Lemstrom K.B., Aho P.T., Bruggeman C.A., et al. Cytomegalovirus infection enhances mRNA expression of platelet-derived growth factor-BB and transforming growth factor-β 1 in rat aortic allografts: possible mechanism for cytomegalovirus-enhanced graft arteriosclerosis. Arterioscler. Thromb. 14:1994;2043-2052.
42. Khachigian L.M., Fries J.W., Benz M.W., et al. Novel cis-acting elements in the human platelet-derived growth factor B-chain core promoter that mediate gene expression in cultured vascular endothelial cells. J. Biol. Chem. 269:1994;22647-22656.
43. Garrett J.S., Narus J.C., Bohnsack J.F., et al. Effects of cytomegalovirus infection on growth factor production in endothelial cells and fibroblasts. Pediatr. Res. 38:1995;1003-1008.
44. Stein J., Volk H.D., Liebenthal C., et al. Tumor necrosis factor α stimulates the activity of the human cytomegalovirus major immediate early enhancer/promoter in immature monocytic cells. J. Gen. Virol. 74:1993;2333-2338.
45. Meier J.L., Stinski M.F. Regulation of human cytomegalovirus immediate-early gene expression. Intervirology. 39:1996;331-342.
46. Lang D., Stamminger T. The 86-kilodalton IE-2 protein of human cytomegalovirus is a sequence-specific DNA-binding protein that interacts directly with the negative autoregulatory response element located near the cap site of the IE-1/2 enhancer-promoter. J. Virol. 67:1993;323-331.
47. Kaplanski G., Fabrigoule M., et al. Thrombin induces endothelial type II activation in vitro: IL-1 and TNF-α-independent IL-8 secretion and E-selectin expression. J. Immunol. 158:1997;5435-5441.
48. Stenberg R.M., Thomsen D.R., Stinski M.F. Structural analysis of the major immediate early gene of human cytomegalovirus. J. Virol. 49:1984;190-199.
49. Nakajima T., Kitajima I., Shin H., et al. Involvement of NF-kappa B activation in thrombin-induced human vascular smooth muscle cell proliferation. Biochem. Biophys. Res. Commun. 204:(2):1994;950-958.
50. Anrather D., Millan M.T., Palmetshofer A., et al. Thrombin activates nuclear factor-κB and potentiates endothelial cell activation by TNF. J. Immunol. 159:1997;5620-5628.
51. Bellas R.E., Lee J.S., Sonenshein G.E. Expression of a constitutive NF-kappa B-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells. J. Clin. Invest. 96:(5):1995;2521-2527.
52. Tanner F.C., Carr D.P., Nabel G.J., et al. Transfection of human endothelial cells. Cardiovasc. Res. 35:1997;522-528.
53. Geist L.J., Monick M.M., Stinski M.F., et al. The immediate early genes of human cytomegalovirus upregulate tumor necrosis factor-a gene expression. J. CIin. Invest. 93:1994;474-478.
54. Iwamoto G.K., Konicek S. Cytomegalovirus immediate early genes upregulate interleukin-6 expression. J. Investig. Med. 45:1997;175-182.
55. Yonemitsu Y., Kaneda Y., Komori K., et al. The immediate early gene of human cytomegalovirus stimulates vascular smooth muscle cell proliferation in vitro and in vivo. Biochem. Biophys. Res. Commun. 231:1997;447-451.
56. Tanaka K., Zou J.P., Takeda K., et al. Effects of human cytomegalovirus immediate-early proteins on p53-mediated apoptosis in coronary artery smooth muscle cells. Circulation. 99:1999;1656-1659.